TUMOR MOLECULAR SUBTYPE AND GUT MICROBIOME ANALYSIS FOR THE PREDICTION OF IMMUNCHECKPOINT INHIBITOR THERAPY IN PATIENTS WITH UROTHELIAL CARCINOMA  Page description

Help  Print 
Back »
 

Details of project

  
Identifier
139059
Type K
Principal investigator Szarvas, Tibor Gábor
Title in Hungarian AZ IMMUNELLENŐRZŐPONT-GÁTLÓ TERÁPIA HATÉKONYSÁGÁNAK ELŐREJELZÉSE HÚGYHÓLYAGDAGANATOS BETEGEKBEN A TUMOR MOLEKULÁRIS MINTÁZATÁNAK, VALAMINT A SZÉKLET MIKROBIOM-ÖSSZETÉTELÉNEK VIZSGÁLATÁVAL
Title in English TUMOR MOLECULAR SUBTYPE AND GUT MICROBIOME ANALYSIS FOR THE PREDICTION OF IMMUNCHECKPOINT INHIBITOR THERAPY IN PATIENTS WITH UROTHELIAL CARCINOMA
Keywords in Hungarian IMMUNTERÁPIA, UROTHELIÁLIS HÓLYAGDAGANAT, MOLEKULÁRIS ALTÍPUSOK, MIKROBIOM, IMMUN SZIGNATÚRA, PD-L1 STÁTUSZ
Keywords in English CHECKPOINT INHIBITOR, UROTHELIAL BLADDER CANCER, MOLECULAR SUBTYPES, MICROBIOME, IMMUNE SIGNATURE, PD-L1 STATUS
Discipline
Nephrology, urology (Council of Medical and Biological Sciences)40 %
Ortelius classification: Nephrology, urology
Cancer and its biological basis (Council of Medical and Biological Sciences)40 %
Ortelius classification: Oncology
Molecular biology (Council of Medical and Biological Sciences)20 %
Ortelius classification: Molecular markers and recognition
Panel Immunity, Cancer and Microbiology
Department or equivalent Dept. of Urology (Semmelweis University)
Participants Kenessey, István
Pásztor-Csizmarik, Anita
Starting date 2021-09-01
Closing date 2025-08-31
Funding (in million HUF) 47.971
FTE (full time equivalent) 6.20
state running project




Back »